Delivery Order SPE2D018D0005-SPE2D325F183D
Award Date
7/1/25
Potential Completion Date
7/7/25
Potential Value
$3.9K
Federal Agency
Medical Supply Chain
Awardee
Ortho-Clinical Diagnostics, Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Medical Supply Chain division of the Defense Department's Defense Health Agency. The $1,767.32 firm fixed-price delivery order is for the supply of 4,568,212,039 units of Anti-A,B Bioclone 15x10ml. The contract has a June 2, 2025 completion date and does not utilize a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified...
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Medical Supply Chain division of the Defense agency. The contract is for the delivery of Blood Group Serum 15S, with a ceiling value of $2,904.77 and a period of performance ending on May 7, 2025. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type. It does not have a set-aside designation, indicating open competition....
This is a $4,418.30 fixed-price delivery order awarded to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer, by the Defense Health Agency for blood group serum supplies. The order has a period of performance ending on November 29, 2024. Ortho-Clinical Diagnostics is a for-profit organization and self-certified HUBZone joint venture that has previously provided medical equipment, reagents, and testing services to federal agencies including the Department of Veterans Affairs and...
This is a $1,832.54 fixed-price delivery order awarded to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Medical Supply Chain division of the Defense agency. The contract is for the supply of ANTI-B BIOCLONE 15X10ML medical products, with a completion date of June 6, 2025. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture registered in SAM.gov and specializes in providing advanced diagnostic solutions to federal healthcare agencies,...
This is a $849,897.70 firm fixed-price purchase order contract awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for blood bank testing supplies and services, with a period of performance ending on September 30, 2028. The contract does not have a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture that has been awarded multiple Indefinite...
This is a fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer. The $1,832.54 contract is for the delivery of 4,565,172,008 units of an anti-B bioclone product. The contract has a period of performance through July 19, 2024 and does not have a set-aside designation. Ortho-Clinical Diagnostics is a for-profit company that has provided medical equipment, reagents, and testing services to various federal...
This is a definitive contract awarded by the Department of the Army Medical Command to Ortho-Clinical Diagnostics Inc., a for-profit organization and self-certified HUBZone joint venture manufacturer, for the provision of blood bank systems and reagents. The $537,455.18 firm fixed price contract has a completion date of September 30, 2022 and was originally awarded on October 1, 2017. There is no set-aside designation mentioned for this contract. Ortho-Clinical Diagnostics is a medical equipment...
This is a $57,096.46 firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 23 (VISN 23) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for the supply of Ortho blood bank reagents and gel cards approved for use with the Ortho gel workstation. The contract has an ultimate completion date of September 30, 2027. No set-aside designation was used for this award. Ortho-Clinical Diagnostics, Inc. is a...
This is a federal contract award from the Medical Supply Chain (an alternate name for the Defense Agency), valued at $1,305.93, awarded to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is a Delivery Order, with a fixed price and economic price adjustment pricing type, and an ultimate completion date of June 20, 2025. It does not have a set-aside designation. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture that specializes...
This federal contract award is for BLOOD BANK REAGENTS SUPPLIES from the Defense Health Agency to Ortho-Clinical Diagnostics Inc., a medical equipment manufacturing company. The $107,946.24 Firm Fixed Price contract is a BPA Call, meaning it was issued under a larger indefinite delivery vehicle. Ortho-Clinical Diagnostics Inc. provides automated in vitro reagents and blood bank reagents to Department of the Army Medical Command and Department of Veterans Affairs hospitals and clinics through...